HP and hepatitis A virus infection: These findings indicate that our fast-growing HM175-HP strain shows potential to help in the development of a new HAV vaccine, reducing the costly and time-consuming procedures of the currently available vaccines against hepatitis A. Further studies are needed to explore the potential of the HM175-HP vaccine in clinical settings.